Breakthrough in diabetes research: Cells produce insulin instead upon artemisinin treatment
FDA-approved artemisinins, since decades used to treat malaria, transform glucagon-producing alpha cells in the pancreas into insulin producing cells – thereby acquiring features of beta cells, the cell type damaged in type 1 diabetes. In an international collaboration, researchers at CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences demonstrated the effect of artemisinins with cutting edge single cell analysis methods and were able to treat diabetic fish, mice and rats with the malaria drug. Their groundbreaking results, published in Cell, provides the basis for a promising new approach towards a cure for type 1 diabetes. (Mehr in: Pressemitteilungen – idw – Informationsdienst Wissenschaft)
Comments are closed.